Quratis
Seocho
About Quratis
Quratis is a biopharmaceutical company specializing in the development of vaccines and therapeutic agents for infectious diseases. Its lead product, QTP101, is a subunit tuberculosis vaccine designed as a BCG booster for adolescents and adults, currently undergoing clinical trials. The company is also developing QTP104, a self-replicating mRNA COVID-19 vaccine, in collaboration with HDT Bio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $36.9M
- Funding stage: IPO
- Last round: Private Equity (Sep 2021)
- Ticker: kosdaq:348080
- Website: quratis.com
- Phone: +82 02 866 0604
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/quratis-53473 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.